Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» mFolfirinox
mFolfirinox
Oncolytics doses first subject in pancreatic cancer trial
Clinical Trials Arena
Fri, 06/21/24 - 11:44 am
Oncolytics
clinical trials
mFolfirinox
metastatic pancreatic cancer
pancreatic cancer